Exploring Traditional Medicine Report of a Symposium
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
6Th ACT Accelerator Facilitation Council Meeting Livestreamed Virtual Meeting, 12 May 2021, 12:30 – 15:00 (CEST)
11 May 2021 6th ACT Accelerator Facilitation Council meeting Livestreamed virtual meeting, 12 May 2021, 12:30 – 15:00 (CEST) Co-hosts: Dr Tedros Adhanom Ghebreyesus, Director General, WHO & Ms Stella Kyriakides, Commissioner for Health and Food Safety, European Commission Co-Chairs: Dr Zweli Mkhize, Minister of Health, South Africa & Mr Dag-Inge Ulstein, Minister of International Development, Norway Primary Objectives • Identify barriers and strategies for increasing uptake and use of COVID-19 tools at country level • Guide COVAX Task Force on strategies to expand COVID-19 vaccine production Draft Provisional Agenda Opening (10 min) 12h30 – Welcome • Co-Chairs & Co-Hosts opening remarks (10 12h40 min) Scale up of vaccine supply to COVAX (1hr 5 min), Chair: South Africa 12h40 – Objective: Guide COVAX Task Force on • Facilitator: Dr Ayoade Olatunbosun-Alakija 13h45 strategies to expand COVID-19 Vaccine • Presentation from Task Force (5 min) production • Interactive Panel (20 min) o Dr Amadou Sall, Director, Institut Pasteur, Senegal o Dr Patrick Soon Shiong, Chairman of the Chan Soon-Shiong Family Foundation, CEO & Chairman ImmunityBio & NantHealth o Dr Ngozi Okonjo-Iweala, Director General, WTO • Council Discussion (33 min) • Task Force comments in response to discussion (5 min) • Chair’s closing remarks (2 min) Health Systems Connector: Facilitating uptake & delivery of COVID-19 tools (60 min), Chair: Norway 13h45 – Objective: Identify barriers and strategies for • Facilitator: Emma Ross 14h45 increasing uptake and use of COVID-19 tools at • Interactive panel (20 min) country level o Dr Faisal Sultan, Special Assistant to Prime Minister on Health, Ministry of National Health Services Regulations & Coordination, Pakistan o Dr W. -
Caste-Based Oppression and the Class Struggle TU Senan CWI-India
Caste-based Oppression and the Class Struggle TU Senan CWI -India 24 December 2014 Leave a comment In 2013, the British government agreed to include caste- based discrimination as an amendment to the Equality Act (2010). An alliance of Tory MPs and caste-based ‘community leaders’, however, successfully stalled its implementation to after the general election. What is behind this opposition? What role does caste play, both in South Asia and Britain? Why is it an important issue for socialists today? The caste system in South Asia is one of the cruellest forms of oppression that exists today. Cold-blooded murder, sexual violence, untouchability, bonded slavery and other feudal forms of horrific discrimination are used against people from the most oppressed caste. People challenging this oppression face brutal violence, including being driven from traditional lands or the burning down of whole villages. More than half-a-billion people in India are subjected to discrimination based on their caste, which is determined by hereditary membership and marriage within the caste. Higher castes dominate certain professions, businesses, etc. Beneath this hierarchical system are more than 200 million (Dalits and others) who face the most severe forms of discrimination. Traditional castes cut across class and class loyalties, although the leaders of the higher castes are a significant component of the ruling class. Caste oppression is also present in other parts of the world where South Asians live, travelling with the migrations of populations over time. From Malaysia to Europe, caste divisions have been maintained. At least half-a- million people of South Asian descent face caste-based discrimination in Britain. -
News Covering in the Online Press Media During the ANC Elective Conference of December 2017 Tigere Paidamoyo Muringa 212556107
News covering in the online press media during the ANC elective conference of December 2017 Tigere Paidamoyo Muringa 212556107 A thesis submitted in fulfilment of the academic requirements for the degree of Doctor of Philosophy (PhD) at Centre for Communication, Media and Society in the School of Applied Human Sciences, College of Humanities, University of KwaZulu-Natal, Durban. Supervisor: Professor Donal McCracken 2019 As the candidate's supervisor, I agree with the submission of this thesis. …………………………………………… Professor Donal McCracken i Declaration - plagiarism I, ……………………………………….………………………., declare that 1. The research reported in this thesis, except where otherwise indicated, is my original research. 2. This thesis has not been submitted for any degree or examination at any other university. 3. This thesis does not contain other persons' data, pictures, graphs or other information unless specifically acknowledged as being sourced from other persons. 4. This thesis does not contain other persons' writing unless specifically acknowledged as being sourced from other researchers. Where other written sources have been quoted, then: a. Their words have been re-written, but the general information attributed to them has been referenced b. Where their exact words have been used, then their writing has been placed in italics and inside quotation marks and referenced. 5. This thesis does not contain text, graphics or tables copied and pasted from the Internet, unless specifically acknowledged, and the source being detailed in the thesis and the References sections. Signed ……………………………………………………………………………… ii Acknowledgements I am greatly indebted to the discipline of CCMS at Howard College, UKZN, led by Professor Ruth Teer-Tomaselli. It was the discipline’s commitment to academic research and academic excellence that attracted me to pursue this degree at CCMS (a choice that I don’t regret). -
Ending Covid Means Ending Aids, and Ending Both Means E
Ending Covid means ending Aids, and ending both means e... MAVERICK CITIZEN: EDITORIAL Ending Covid means ending Aids, and ending both means ending inequality By Mark Heywood • 14 June 2021 Faceboo Twitter Print Email AddThis 17 Ending Covid means ending Aids and ending both means ending inequality. (Photo: forbes.… When it comes to communicable diseases, the lesson we should take from Covid-19 is that one person is all it takes to start a devastating pandemic. Is that fact enough of a wake-up for governments to seriously tackle the social and economic determinants of health and disease? https://www.dailymaverick.co.za/article/2021-06-14-ending-covid-means-ending-aids-and-ending-both-means-ending-inequality/[2021/06/15 1:25:12 PM] Ending Covid means ending Aids, and ending both means e... Last week, at the opening of the tenth South African Aids Conference, X Professor Salim Abdool Karim made a plenary presentation titled “HIV and Covid-19 in South Africa”. It revealed how interdependent the HIV/Aids and Covid-19 pandemics are becoming. Professor Salim Abdool Karim. (Photo: Dean Demos) In an overview, “SARS-CoV-2 infection in people living with HIV”, Karim referred to the case of a patient whose immune system was almost entirely suppressed because of HIV and who, as a result, experienced an acute Covid-19 infection that persisted over six months. Eventually, when she was put on to a new and effective regimen of antiretroviral medicines (ARVs) her immune system rebounded and she also recovered quickly from Covid-19. This was the good news. -
Covid-19: South Africa Pauses Use of Oxford Vaccine After
NEWS BMJ: first published as 10.1136/bmj.n372 on 8 February 2021. Downloaded from The BMJ Cite this as: BMJ 2021;372:n372 Covid-19: South Africa pauses use of Oxford vaccine after study casts http://dx.doi.org/10.1136/bmj.n372 doubt on efficacy against variant Published: 08 February 2021 Elisabeth Mahase Rollout of the Oxford-AstraZeneca covid-19 vaccine is going to be hard to estimate. Without seeing results in South Africa has been paused after a study in 2000 in detail it isn’t possible to be sure how firm these healthy and young volunteers reported that it did not conclusions are. protect against mild and moderate disease caused by “However, if the press reports are correct it does seem the new variant (501Y.V2) that emerged there. of concern that protection against disease was not The study, which has not been published and was shown. The findings of the Novavax vaccine trial of seen by the Financial Times,1 looked at the efficacy 60% efficacy in the prevention of disease of any of the vaccine against the 501Y.V2 variant—which severity in HIV negative volunteers in South Africa accounts for around 90% of cases in South Africa—in might also suggest that vaccines will need to be HIV negative people. While reports suggested that updated in line with emerging mutations of the the vaccine was ineffective at preventing mild to virus.” moderate disease in that population, no data have 1 Mancini DP, Kuchler H, Pilling D, Cookson C, Cotterill J. Oxford/AstraZeneca been made available to the public. -
Cabinet Factsheet [PDF]
Cabinet held its scheduled virtual Meeting on Wednesday, 10 June 2020 1. CABINET DECISIONS On 31 December 2019, the World Health Organization (WHO) reported a cluster of pneumonia cases in Update on Coronavirus Wuhan City, China. ‘Severe Acute Respiratory Syndrome Coronavirus 2’ (SARS-CoV-2) was confirmed commissioned within the (COVID-19) as the causative agent of what we now know as ‘Coronavirus Disease 2019’ (COVID-19). Since then, context of the Resistance Cabinet held itsthe scheduled virus has spread to more virtual than 100 countries, Meeting including South onAfrica. Wednesday, 10 June 2020 ● Cabinet receivedCabinet an updated held its virtual Meeting on Wednesday, 24 June and2020 Liberation Heritage report from the National Route (RLHR) Project. The CoronavirusOn Wednesday, Command Council 21 AprilCOVID-19 2021 is , anCabinet infectious held disease its thatfirst is physical spread, meetingRLHR sincecontributes the towards CABINET1.introduction(NCCC). CABINET DECISIONS DECISIONSof the national lockdowndirectly or indirectly, in 2020. from oneThis person is part to another. of Cabinet transitioningthe development and itself The NCCC tabled a number of transformation of the South ● Infection: recommendations pertainingto the new normal as the countryto drive the multidisciplinary continues gov- to reopen itself.African heritage landscape. On 31 December 2019, the World Health Organization (WHO) reported a cluster of pneumonia cases in to the enhanced risk adjusted An infected person can spread the virusernment to a healthy interventions. person through: However, Update on Coronavirus Wuhan City, China. ‘Severe Acute Respiratory Syndrome Coronavirus 2’ (SARS-CoV-2) was confirmed commissioned within the the eye, nose and mouth or through droplets produced on coughing or sneezing. -
An in Silico Study of the Ligand Binding to Human Cytochrome P450 2D6
AN IN SILICO STUDY OF THE LIGAND BINDING TO HUMAN CYTOCHROME P450 2D6 Sui-Lin Mo (Doctor of Philosophy) Discipline of Chinese Medicine School of Health Sciences RMIT University, Victoria, Australia January 2011 i Declaration I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at RMIT university or any other educational institution, except where due acknowledgment is made in the thesis. Any contribution made to the research by others, with whom I have worked at RMIT university or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project‘s design and conception or in style, presentation and linguistic expression is acknowledged. PhD Candidate: Sui-Lin Mo Date: January 2011 ii Acknowledgements I would like to take this opportunity to express my gratitude to my supervisor, Professor Shu-Feng Zhou, for his excellent supervision. I thank him for his kindness, encouragement, patience, enthusiasm, ideas, and comments and for the opportunity that he has given me. I thank my co-supervisor, A/Prof. Chun-Guang Li, for his valuable support, suggestions, comments, which have contributed towards the success of this thesis. I express my great respect to Prof. Min Huang, Dean of School of Pharmaceutical Sciences at Sun Yat-sen University in P.R.China, for his valuable support. -
TO: Mr. Peter Sands, Global Fund to Fight AIDS, TB, and Malaria Dr. Tedros Adhanom Ghebreyesus, World Health Organization Dr. Ca
TO: Mr. Peter Sands, Global Fund to Fight AIDS, TB, and Malaria Dr. Tedros Adhanom Ghebreyesus, World Health Organization Dr. Catharina Boehme, World Health Organization Dr. Sergio Carmona, FIND Dr. Philippe Duneton, Unitaid Mr. Ira Magaziner, CHAI Ms. Etleva Kadilli, UNICEF Dr. OlusoJi Adeyi, World BanK Ms. Adriana Costa, World BanK Dr. Emilio Emini, Bill & Melinda Gates Foundation Dr. John NKengasong, Africa CDC Dr. BenJamin DJoudalbaye, African Union Mr. Nqobile Ndlovu, African Society for Laboratory Medicine Honorable Zweli Mkhize, National Department of Health, South Africa Honorable Rajesh Bhushan, Ministry of Health and Family Welfare, India Honorable Eduardo Pazuello, Ministry of Health, Brazil Honorable Mutahi Kagwe, Ministry of Health, Kenya Mr. Balram Bhargava, Indian Council of Medical Research Dr. Jarbas Barbosa, PAHO Ms. Gloria D. Steele, USAID Global Fund Members of the Board Unitaid Members of the Board ACT-A Facilitation Council Members ACT-A Diagnostics Pillar and Diagnostics Consortium Members Integrated Diagnostics Consortium Members CC: Mr. Warren C. Kocmond, President and Chief Operating Officer, Cepheid Mr. Philippe Jacon, President, Global Access, Cepheid 1 April 2021 Dear Colleagues, On 25 February 2021, 108 civil society organizations sent an open letter to Cepheid requesting that the company increase access to Xpert SARS-CoV-2 tests in low- and middle-income countries (LMICs) by committing a greater proportion of Cepheid’s manufacturing capacity to LMICs and by lowering the prices of Xpert tests for SARS-CoV-2 -
Brazilian Journal of Strategy & International Relations Revista
ISSN 2238-6262 / e-ISSN 2238-6912 Brazilian Journal of Strategy & International Relations Revista Brasileira de Estratégia e Relações Internacionais Porto Alegre, v.7, n.13 | Jan./Jun. 2018 Austral Porto Alegre v.7, n.13 p. 1-323 Jan./Jun. 2018 About the Journal AUSTRAL: Brazilian Journal of Strategy and International Relations was the first Brazilian journal in the area of International Relations to be fully pub- lished in English (2012). It is an essentially academic vehicle, linked to the Brazil- ian Centre for Strategy & International Relations (NERINT) and the Doctoral Pro- gram in International Strategic Studies (PPGEEI) of the Faculty of Economics (FCE) of the Universidade Federal do Rio Grande do Sul (UFRGS). Its pluralist focus aims to contribute to the debate on the international political and economic order from the perspective of the developing world. The journal publishes original articles in the area of Strategy and Inter- national Relations, with special interest in issues related to developing countries and South-South Cooperation – its security problems; the political, economic and diplomatic developments of emerging countries; and their relations with the traditional powers. AUSTRAL is published semi-annually in English and Portu- guese. The journal’s target audience consists of researchers, experts, diplomats, military personnel and graduate students of International Relations. The content of the journal consists of in-depth analytical articles written by experts (Professors and Doctors), focusing on each of the great continents of the South: Asia, Latin America and Africa. Thus, the debate and diffusion of knowledge produced in these regions is stimulated. All contributions submitted to AUSTRAL are subject to rigorous scientific evaluation. -
Civil Society Letter to Cepheid Requesting Lower Prices for Xpert SARS-Cov-2 Tests and Increased
Mr. Warren C. Kocmond President and Chief Operating Officer Cepheid 904 Caribbean Drive Sunnyvale, CA 94089 United States CC: Mr. Philippe Jacon, President, Global Access, Cepheid Mr. Peter Sands, Global Fund to Fight AIDS, TB, and Malaria Dr. Tedros Adhanom Ghebreyesus, World Health Organization Dr. Catharina Boehme, FIND Dr. Philippe Duneton, Unitaid Mr. Ira Magaziner, CHAI Ms. Etleva Kadilli, UNICEF Dr. Olusoji Adeyi, World Bank Dr. Emilio Emini, Bill & Melinda Gates Foundation Dr. John Nkengasong, Africa CDC Dr. Benjamin Djoudalbaye, African Union Mr. Nqobile Ndlovu, African Society for Laboratory Medicine Honorable Zweli Mkhize, National Department of Health, South Africa Honorable Rajesh Bhushan, Ministry of Health and Family Welfare, India Honorable Eduardo Pazuello, Ministry of Health, Brazil Honorable Mutahi Kagwe, Ministry of Health, Kenya Mr. Balram Bhargava, Indian Council of Medical Research Dr. Jarbas Barbosa, PAHO Ms. Gloria D. Steele, USAID Global Fund Members of the Board Unitaid Members of the Board ACT-A Facilitation Council Members ACT-A Diagnostics Pillar and Diagnostics Consortium Members Integrated Diagnostics Consortium Members 25 February 2021 Dear Mr. Kocmond, The World is grappling with not only a devastating global COVID-19 pandemic but also inadequate access to affordable medical tools, including diagnostics. The 108 civil society organizations below are Writing out of deep concern about the lack of access to Cepheid’s GeneXpert SARS-CoV-2 tests in low- and middle-income countries (LMICs). We are Writing to request that Cepheid increase access to these tests by committing a greater proportion of its COVID-19 manufacturing capacity to LMICs and by lowering the price of its cartridges. -
Review Article Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy
Hindawi Publishing Corporation Neural Plasticity Volume 2016, Article ID 1320423, 18 pages http://dx.doi.org/10.1155/2016/1320423 Review Article Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy James Ahn,1 Hyung Seok Ahn,2 Jae Hoon Cheong,3 and Ike dela Peña1 1 Department of Pharmaceutical and Administrative Sciences, Loma Linda University, Loma Linda, CA 92350, USA 2School of Medicine, Chungnam National University, Daejeon 301-747, Republic of Korea 3Department of Pharmacy, Sahmyook University, Seoul 139-742, Republic of Korea Correspondence should be addressed to Ike dela Pena;˜ [email protected] Received 9 November 2015; Revised 30 December 2015; Accepted 10 January 2016 Academic Editor: Daniel Fung Copyright © 2016 James Ahn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Typical treatment plans for attention-deficit/hyperactivity disorder (ADHD) utilize nonpharmacological (behavioral/psychosocial) and/or pharmacological interventions. Limited accessibility to behavioral therapies and concerns over adverse effects of pharmacological treatments prompted research for alternative ADHD therapies such as natural product-derived treatments and nutritional supplements. In this study, we reviewed the herbal preparations and nutritional supplements evaluated in clinical studies as potential ADHD treatments and discussed their performance with regard to safety and efficacy in clinical trials. We also discussed some evidence suggesting that adjunct treatment of these agents (with another botanical agent or pharmacological ADHD treatments) may be a promising approach to treat ADHD. -
Moerane Commission Report
REPORT OF THE MOERANE COMMISSION OF ENQUIRY INTO THE UNDERLYING CAUSES OF THE MURDER OF POLITICIANS IN KWAZULU- NATAL Contents INTRODUCTION ....................................................................................................................................... 2 ANALYSIS OF THE TERMS OF REFERENCE ............................................................................................... 7 WITNESSES ............................................................................................................................................ 10 THE EVIDENCE ....................................................................................................................................... 18 FINDINGS ............................................................................................................................................. 412 RECOMMENDATIONS ......................................................................................................................... 417 ACKNOWLEDGMENTS ......................................................................................................................... 424 1 | P a g e INTRODUCTION 1. “Something is rotten in the State of Denmark.”1 2. Had Shakespeare lived in KwaZulu-Natal (KZN) between the years 2011 and today, he might have had a modern-day Marcellus utter those words – a theme to which we shall return. For present purposes, suffice it to say that the apparently never-ending murder of politicians in KZN is a symptom of a serious pathology in the Province’s